Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2001.308 | VITAMINS TO PREVENT STROKE (VITATOPS) STUDY: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Examining the Efficacy and Safety of Multi-Vitamin Therapy in Secondary Stroke Prevention | Prof. Wong Ka Sing Lawrence |
| 2001.263 | The Use of Traditional Chinese Medicine in Treatment of Nasopharyngeal Carcinoma | Prof. Chan TC Anthony |
| 2001.249 | Prospective Randomized Study on Amifostine During Primary Radical Radiotherapy for Nasopharyngeal Carcinoma(NPC) | Prof. Chan T.C. Anthony |
| 2001.238 | Randomised Double-blind Trial in Postmenopausal Women with Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 years, Comparing Subsequent Adjuvant Exemestane Treatment with Further Tamoxifen | Prof. Yeo Winnie |
| 2001.233 | A Randomized, Multi-centre, Double-blind, Double-dummy, Parallel Group Trial of Two Doses of NNC 61-0029 in Combination with Glibenclamide Versus Glibenclamide Monotherapy and Versus Combination Therapy of Glibenclamide and Metformin in the Treatment of Subjects with Type 2 Diabetes | Dr. Chow C.C. Francis |
| 2001.205 | Biweekly Irinotecan(CPT-11), 5 Fluorouracil (5FU) and Folinic Acid (FA) in Unresectable Liver Metastastes from Colorectal Cancer: A Phase II Study | Prof. Chan T.C. Anthony |
| 2001.115 | Proton Pump Inhibitor for Uninvestigated H.Pylori-negative Dyspeptic Patients | Prof. Leung Wai Keung |
| 2001.053 | Randomised controlled trial of Levo-norgestrel intrauterine system in women receiving tamoxifen for carcinoma of breast | Dr. Chan Shing Chee Symphorosa |
| 2000.447 | Pre and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases from Colorectal Origin Phase III Randomized Study | Prof. CHAN Anthony T.C. |
| 2000.422 | A Multicentre, Randomized, Double-blind, Controlled Study of Two Corticosteroid Regimens for Treatment of Systemic Hypotension in Preterm Infants | Prof. Ng Pak Cheung |
| 9406(S) | A Prospective Randomized Phase III Study Comparing the Combination of Cisplatin, Doxorubicin, Interferon-Alpha-2B and 5-Fluorouracil to Doxorubicin Alone in the Treatment of Inoperable Hepatocellular Carcinoma | Prof. YEO Winnie |
Page 254 of 254.